Actively Recruiting
Safety of Cyberknife in Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma
Led by Capital Health System, Inc · Updated on 2023-03-31
10
Participants Needed
1
Research Sites
313 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The hypothesize that SBRT will limit or reverse tumor growth and thereby convert the borderline resectable disease or locally advanced disease in to a resectable tumor. Furthermore, we want to assess whether SBRT leads to an improved quality of life compared to IMRT.
CONDITIONS
Official Title
Safety of Cyberknife in Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Able to sign the informed consent and understand the consenting process
- Completed neoadjuvant chemotherapy regimen
- Patient is 18 years of age and older
- Eastern Cooperative Oncology Group (ECOG) Status of 0-1
- Diagnosis of Stage I to Stage III pancreatic cancer confirmed by cytology or pathology based on imaging or exploratory laparoscopic surgery, with low arterial involvement and no aorta involvement
- Eligible for IMRT or SBRT and approved for radiation therapy by multidisciplinary tumor board
- No evidence of disease progression to distant metastasis based on NCCN guidelines
- Negative pregnancy test
You will not qualify if you...
- Pregnant or lactating female patients not willing to use highly effective birth control from screening to 6 months after last radiation dose
- Resectable pancreatic cancer
- Unresectable pancreatic cancer
- Unable to tolerate general anesthetic with full skeletal muscle blockade
- Presence of implanted cardiac pacemakers, defibrillators, electronic devices, or metal parts in thoracic cavity
- Life expectancy less than 1 year
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Capital Health Medical Center-Hopewell
Pennington, New Jersey, United States, 08534
Actively Recruiting
Research Team
S
Shirnett Williamson, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here